A panel of medical experts overwhelmingly recommended Thursday that US regulators green-light a COVID-19 vaccine developed by Cambridge-based Moderna, paving the way for a second vaccine in the drive to immunize tens of millions of Americans against the deadly coronavirus.
Read the full story on BostonGlobe.com.
|
|
|
|
|
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
|
|
|
|
